- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02173236
The Effect of Platform Switching on Single Implants in the Esthetic Zone, Following Flapless Surgery and Early-Loading Protocols
June 23, 2014 updated by: Yung-Ting Hsu, University of Michigan
The impact of platform switching with flapless surgery on early-loaded single-tooth implants on esthetic outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Evaluation of clinical, radiographic and microbial outcomes of single implants with platform switching, compared to those with conventional platform.
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109-1078
- Graduate Periodontics, Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients should be at least 18 years old and not currently pregnant
- Systemically healthy with no medical contraindications to implant surgery
- Having intact opposite tooth to proposed implant sites
- The edentulous ridge with minimal ridge deformities.
Exclusion Criteria:
- unstable medical status or conditions which may compromise wound healing
- osseous metabolic disorders (e.g., osteoporosis, Paget's disease etc.)
- uncontrolled dental or periodontal diseases
- edentulous ridges with the presence of fibrous dysplasia, severe tissue undercut, residual root, as well as insufficient dimensions or volume
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: platform-switched implants
platform-switched implants vs. platform-matched implants
|
Other Names:
|
Active Comparator: platform-matched implants
platform-switched implants vs. platform-matched implants
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
plaque index
Time Frame: crown placement
|
(Silness and Loe 1964).
0 represented the absence of plaque. 1 was the presence of plaque at gingival margin.
2 was the presence of visible plaque; whereas 3 was recorded if abundant plaque was observed
|
crown placement
|
plaque index
Time Frame: post-loading 3 months
|
(Silness and Loe 1964).
0 represented the absence of plaque. 1 was the presence of plaque at gingival margin.
2 was the presence of visible plaque; whereas 3 was recorded if abundant plaque was observed
|
post-loading 3 months
|
plaque index
Time Frame: post-loading 6 months
|
(Silness and Loe 1964).
0 represented the absence of plaque. 1 was the presence of plaque at gingival margin.
2 was the presence of visible plaque; whereas 3 was recorded if abundant plaque was observed
|
post-loading 6 months
|
plaque index
Time Frame: post-loading 12 months
|
(Silness and Loe 1964).
0 represented the absence of plaque. 1 was the presence of plaque at gingival margin.
2 was the presence of visible plaque; whereas 3 was recorded if abundant plaque was observed
|
post-loading 12 months
|
gingival index
Time Frame: crown placement
|
(Loe 1967) As for GI, normal gingival was scored as 0. 1 meant the presence of mild inflammation, slight change in color, slight edema and no BOP.
Moderate inflammation was represented by 2, inclusive of the presence of gingival redness, edema, glazing and BOP.
Severe inflammation with marked redness, edema, ulceration and spontaneous bleeding was scaled as 3
|
crown placement
|
gingival index
Time Frame: post-loading 3 months
|
As for GI, normal gingival was scored as 0. 1 meant the presence of mild inflammation, slight change in color, slight edema and no BOP.
Moderate inflammation was represented by 2, inclusive of the presence of gingival redness, edema, glazing and BOP.
Severe inflammation with marked redness, edema, ulceration and spontaneous bleeding was scaled as 3
|
post-loading 3 months
|
gingival index
Time Frame: post-loading 6 months
|
As for GI, normal gingival was scored as 0. 1 meant the presence of mild inflammation, slight change in color, slight edema and no BOP.
Moderate inflammation was represented by 2, inclusive of the presence of gingival redness, edema, glazing and BOP.
Severe inflammation with marked redness, edema, ulceration and spontaneous bleeding was scaled as 3
|
post-loading 6 months
|
gingival index
Time Frame: post-loading 12 months
|
As for GI, normal gingival was scored as 0. 1 meant the presence of mild inflammation, slight change in color, slight edema and no BOP.
Moderate inflammation was represented by 2, inclusive of the presence of gingival redness, edema, glazing and BOP.
Severe inflammation with marked redness, edema, ulceration and spontaneous bleeding was scaled as 3
|
post-loading 12 months
|
Papillary index
Time Frame: crown placement
|
(Jemt 1997) 0 = the absence of papilla, 1= <50% of the height of the gingival embrasure, 2= 50-99% of the height of the gingival embrasure, 3 = 100% of the proximal space, 4= overgrowth of the interproximal tissue
|
crown placement
|
Papillary index
Time Frame: post-loading 3 months
|
(Jemt 1997) 0 = the absence of papilla, 1= <50% of the height of the gingival embrasure, 2= 50-99% of the height of the gingival embrasure, 3 = 100% of the proximal space, 4= overgrowth of the interproximal tissue
|
post-loading 3 months
|
Papillary index
Time Frame: post-loading 6 months
|
(Jemt 1997) 0 = the absence of papilla, 1= <50% of the height of the gingival embrasure, 2= 50-99% of the height of the gingival embrasure, 3 = 100% of the proximal space, 4= overgrowth of the interproximal tissue
|
post-loading 6 months
|
Papillary index
Time Frame: post-loading 12 months
|
(Jemt 1997) 0 = the absence of papilla, 1= <50% of the height of the gingival embrasure, 2= 50-99% of the height of the gingival embrasure, 3 = 100% of the proximal space, 4= overgrowth of the interproximal tissue
|
post-loading 12 months
|
The width of keratinized mucosa
Time Frame: crown placement
|
measured at the midpoint on mid-facial surfaces of implants and adjacent two teeth.
|
crown placement
|
The width of keratinized mucosa
Time Frame: post-loading 3 months
|
measured at the midpoint on mid-facial surfaces of implants and adjacent two teeth.
|
post-loading 3 months
|
The width of keratinized mucosa
Time Frame: post-loading 6 months
|
measured at the midpoint on mid-facial surfaces of implants and adjacent two teeth.
|
post-loading 6 months
|
The width of keratinized mucosa
Time Frame: post-loading 12 months
|
measured at the midpoint on mid-facial surfaces of implants and adjacent two teeth.
|
post-loading 12 months
|
Soft tissue level
Time Frame: crown placement
|
the vertical distance from the gingival margin to the line connecting the facial gingival margin of two adjacent teeth
|
crown placement
|
Soft tissue level
Time Frame: post-loading 3 months
|
the vertical distance from the gingival margin to the line connecting the facial gingival margin of two adjacent teeth
|
post-loading 3 months
|
Soft tissue level
Time Frame: post-loading 6 months
|
the vertical distance from the gingival margin to the line connecting the facial gingival margin of two adjacent teeth
|
post-loading 6 months
|
Soft tissue level
Time Frame: post-loading 12 months
|
the vertical distance from the gingival margin to the line connecting the facial gingival margin of two adjacent teeth
|
post-loading 12 months
|
Probing depth
Time Frame: crown placement
|
Probing depth (PD) on the implant has also been recorded at 6 points mesiobuccal, buccal, distobuccal, mesiolingual, lingual, distolingual line-angles
|
crown placement
|
Probing depth
Time Frame: post-loading 3 months
|
Probing depth (PD) on the implant has also been recorded at 6 points mesiobuccal, buccal, distobuccal, mesiolingual, lingual, distolingual line-angles
|
post-loading 3 months
|
Probing depth
Time Frame: post-loading 6 months
|
Probing depth (PD) on the implant has also been recorded at 6 points mesiobuccal, buccal, distobuccal, mesiolingual, lingual, distolingual line-angles
|
post-loading 6 months
|
Probing depth
Time Frame: post-loading 12 months
|
Probing depth (PD) on the implant has also been recorded at 6 points mesiobuccal, buccal, distobuccal, mesiolingual, lingual, distolingual line-angles
|
post-loading 12 months
|
marginal bone level changes
Time Frame: post-operative 2 weeks, immediately after crown delivery, 3, 6, and 12 months post-loading
|
the vertical distance between alveolar crest to platform level (both mesial and distal)
|
post-operative 2 weeks, immediately after crown delivery, 3, 6, and 12 months post-loading
|
ridge height
Time Frame: prior to surgery
|
the distance from the highest point of alveolar crest to the base of the maxillary arch
|
prior to surgery
|
ridge height
Time Frame: post-loading 12 months
|
the distance from the highest point of alveolar crest to the base of the maxillary arch
|
post-loading 12 months
|
ridge width 3mm below crest
Time Frame: prior to surgery
|
the distance between the most prominent point on labial and palatal surfaces at the level of 3mm below the crest
|
prior to surgery
|
ridge width 3mm below crest
Time Frame: post-loading 12 months
|
the distance between the most prominent point on labial and palatal surfaces at the level of 3mm below the crest
|
post-loading 12 months
|
ridge width 10 mm below crest
Time Frame: prior to surgery
|
the distance between the most prominent point on labial and palatal surfaces at the level of 10 mm below the crest
|
prior to surgery
|
ridge width 10 mm below crest
Time Frame: post-loading 12 months
|
the distance between the most prominent point on labial and palatal surfaces at the level of 10 mm below the crest
|
post-loading 12 months
|
the presence of perforation or dehiscence
Time Frame: post-loading 1 year
|
using CBCT scan
|
post-loading 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
post-op experience
Time Frame: post-op 2weeks
|
pain, bleeding, swelling and overall discomfort
|
post-op 2weeks
|
microbial analysis
Time Frame: 12 months after loading
|
peri-implant microbial profile
|
12 months after loading
|
post-loading experience
Time Frame: post-op 12 months
|
comfort, function (chewing/speaking), esthetics, and overall satisfaction
|
post-op 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2011
Primary Completion (Actual)
March 1, 2014
Study Completion (Actual)
March 1, 2014
Study Registration Dates
First Submitted
June 19, 2014
First Submitted That Met QC Criteria
June 23, 2014
First Posted (Estimate)
June 24, 2014
Study Record Updates
Last Update Posted (Estimate)
June 24, 2014
Last Update Submitted That Met QC Criteria
June 23, 2014
Last Verified
June 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- UM-
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on the Impact of Platform-switching
-
National Taiwan University HospitalUnknownEvaluate the Impact of the CDSSTaiwan
-
University Hospital, Strasbourg, FranceCompletedStudy the Impact of Head Position
-
National Taiwan University HospitalRecruiting
-
University of California, San FranciscoFood and Drug Administration (FDA)RecruitingThe Impact of Excipients on Drug AbsorptionUnited States
-
RWTH Aachen UniversityUnknownThe Impact of Oxytocin on Social CognitionGermany
-
Centre hospitalier de Ville-Evrard, FranceUnknownIdentify the Psychological Impact of ContainmentFrance
-
WestEdDepartment of Health and Human Services; Urban StrategiesRecruitingStudy Will Examine the Impact of Project WithUnited States
-
ChromoLogic, LLCUniversity of California, Los AngelesCompletedThe Impact of Whole Body Irradiation on Ocular FlareUnited States
-
Medical University of GrazJoanneum Research Forschungsgesellschaft mbHCompletedThe Impact of Adipose Tissue Quality on Fat Graft RetentionAustria
-
Newcastle UniversityLinkoeping UniversityUnknownThe Impact of Vitamin c and Epicatechin Upon Antioxidant CapactityUnited Kingdom
Clinical Trials on platform-matched implant
-
University of LouisvilleCompleted
-
Implantology InstituteUnknownBone Loss | ImplantsPortugal
-
Søren JepsenCompletedInfluence of Platform-switching on Bone Level Alterations: a 3 Year Randomized Clinical Trial (RCT).Periimplant Crestal Bone Level Changes
-
Cairo UniversityCompleted
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseBelgium, France, Germany, United Kingdom
-
ZimVieRecruitingEdentulous JawUnited States, Germany
-
Farhan KarimDePuy SynthesRecruitingDegenerative Disc Disease | Lumbar Spinal Stenosis | Lumbar Spondylolisthesis | Foraminal StenosisUnited States
-
Universidade Federal de PernambucoUnknownExercise | Kidney TransplantationBrazil
-
Kafrelsheikh UniversityCompletedPeri-implant Mucositis | Dental Implant FailedEgypt
-
University of GeorgiaEmory UniversityActive, not recruitingCerebral Palsy, SpasticUnited States